Smart drug delivery system may help treat spinal cord injuries and other neurological disorders

A Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

The system, which uses extremely thin biomaterials implanted in the body, also protects nerve fibers (axons) that connect nerve cells in injured neural tissues, according to a study in the journal Advanced Materials.

Inflammation typically is a major factor during recovery from central nervous system diseases and injuries. Some regenerative medicine approaches have shown great potential for treating spinal cord injuries, traumatic brain injuries, Alzheimer's disease, Parkinson's disease, stroke and other neurological disorders. But suppressing the immune system during treatment can lead to side effects and boost the risk of infection.

A major goal is to suppress neuroinflammation and restore a healthy micro-environment at sites of neurological disorders. Our system took four years to develop and has shown enormous potential for smart drug delivery for better treatment of neurological disorders."

KiBum Lee, Study Senior Author and Professor, Department of Chemistry and Chemical Biology, School of Arts and Sciences, Rutgers University-New Brunswick.

The team's unique drug delivery system consists of ultrathin nanomaterials, sugar polymers and neural proteins. The system, which releases an anti-inflammatory molecule (methylprednisolone), can create a favorable micro-environment to promote tissue repair and recovery after neurological injury.

By developing innovative, multifunctional and reliable drug delivery systems that use nano-biomaterials, Lee's research group aims to improve the treatment of neurological disorders.

The team believes the new system may pave the way for treating not only central nervous system injuries, but also other diseases, since inflammation generally is associated with a variety of problems such as cardiovascular disease, osteoarthritis, diabetes and cancer.

Source:
Journal reference:

Yang, L., et al. (2020) Effective Modulation of CNS Inhibitory Microenvironment using Bioinspired Hybrid‐Nanoscaffold‐Based Therapeutic Interventions. Advanced Materials. doi.org/10.1002/adma.202002578.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rutgers University. (2022, December 19). Smart drug delivery system may help treat spinal cord injuries and other neurological disorders. AZoLifeSciences. Retrieved on May 26, 2024 from https://www.azolifesciences.com/news/20200918/Smart-drug-delivery-system-may-help-treat-spinal-cord-injuries-and-other-neurological-disorders.aspx.

  • MLA

    Rutgers University. "Smart drug delivery system may help treat spinal cord injuries and other neurological disorders". AZoLifeSciences. 26 May 2024. <https://www.azolifesciences.com/news/20200918/Smart-drug-delivery-system-may-help-treat-spinal-cord-injuries-and-other-neurological-disorders.aspx>.

  • Chicago

    Rutgers University. "Smart drug delivery system may help treat spinal cord injuries and other neurological disorders". AZoLifeSciences. https://www.azolifesciences.com/news/20200918/Smart-drug-delivery-system-may-help-treat-spinal-cord-injuries-and-other-neurological-disorders.aspx. (accessed May 26, 2024).

  • Harvard

    Rutgers University. 2022. Smart drug delivery system may help treat spinal cord injuries and other neurological disorders. AZoLifeSciences, viewed 26 May 2024, https://www.azolifesciences.com/news/20200918/Smart-drug-delivery-system-may-help-treat-spinal-cord-injuries-and-other-neurological-disorders.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug to tackle complex cases of UTI